October 12th, 2023

Life Sciences BC seeks to raise the profile of our members and supporters, highlight their achievements, and promote BC's dynamic life sciences ecosystem. If you have news or a story to share, let us know. You can find previous editions of BioLinks newsletters and other resources on our website at News/Publications.

The province is also providing $2.4M to establish an endowed UBC research chair focused on accelerating the province’s capacity to design and conduct trials for next-gen therapeutics. 

Michael Smith Health Research BC has contributed $1.2M to support these initiatives, helping make BC a world-class clinical trials destination! Learn more.

This week, I was delighted to participate in an engaging discussion hosted by the Greater Vancouver Board of Trade with regional leaders, including The Honourable Selina Robinson, BC Minister of Post Secondary Education & Future Skills.

The conversation focused on how industry, academia, and government are working together to address BC’s talent needs now and in the future!

LSBC was thrilled to co-host a booth with Invest Vancouver at this year’s MedTech Conference in Anaheim, CA. This sector-leading event features world-class speakers, a comprehensive educational program, networking opportunities with the global MedTech community, and insights into cutting-edge technologies. We were proud to see several BC companies participating in various panels and presentations, including ARC Medical, Canary Medical, QARALOGIC, Response Biomedical, and Total Flow Medical. Learn more about BC's notable MedTech companies captured in our conference booklet here. Congratulations to AdvaMed for hosting another great event!

Pictured: Ryan Butt of LSBC, Hillary Pierce of Total Flow Medical.

2024 IRP Participants Announced!

We're pleased to announce the outstanding companies and mentors participating in our 4th annual Investor Readiness Program (IRP)! This focused six-month initiative unites promising small and mid-sized enterprises (SMEs) within BC's dynamic life sciences sector with experienced Entrepreneurs-in-Residence (EIRs), all aimed at equipping these businesses to attract investors.

Congratulations to the selected companies, and thank you to our EIRs for generously giving back to our sector. Thanks also to the National Research Council Canada Industrial Research Assistance Program (NRC IRAP) for their continued partnership and support. Here's to another great year with an exciting cohort!

Read our press release here. Learn more about our IRP program here.

Join us on Nov. 29th and 30th for BioBasics 101, a two-day immersive course presented by LSBC and Biotech Primer, tailored for non-scientists who want to gain foundational knowledge of biopharma, decode industry jargon, and get comfortable with the essentials of the biotech landscape.

Day one addresses DNA, RNA, proteins, and cell signalling, while day two delves into genetic diseases and the world of personalized medicine. You'll learn about small-molecule drugs, biologics, and vaccines and walk away with a better fluency with and understanding of the biopharma industry. Earlybird registration is available until Oct. 29 - bring your team! Learn more.

Member Highlights 

Ali Ardakani of Novateur Ventures and LSBC Board Chair, in partnership with the Biotechnology Innovation Organization (BIO), is offering a complimentary 2024 JP Morgan Week Event Guide Mobile App. Conference participants are invited to contribute their events to this guide free of charge. You can add your events here. Additionally, you can click here to download the 2023 version of the app and get the updated 2024 version when available. Learn more about JPM'24 here.

SFU's ImageTech Lab at Surrey Memorial Hospital has acquired the TRIUX™ neo technology from MEGIN, a Finnish neuroscience tech company. This technology enhances brain research and the understanding of brain diseases and injuries by offering advanced magnetoencephalography capabilities for adult and pediatric scans. Learn more.

Alvin Yang of Innovative Targeting is donating the following used but functioning lab equipment to local biotech companies and educational institutions on a first come, first served basis. Reach out to ayang@innovativetargeting.com for details.

• Bio-Rad Ultramark Microplate Reader
• Bio-Rad Electroporation components: Genepulser II, Pulse Controller II, Capacitance Extender II
• Taylor Wharton LS4800 Liquid Nitrogen Dewar/Cryostorage
• Nikon Eclipse E600 Research Microscope

Abdera CEO Lori Lyons-Williams is featured on the Timmerman Report's The Long Run podcast, discussing her career journey and the potential impact of targeted radiopharmaceuticals on difficult-to-treat tumours. Listen here.

New Members

We are pleased to welcome the following new LSBC Members: 

UBC Venture Funds invests risk capital in new and innovative startups founded by UBC students, alums, faculty and staff.

PHC Ventures provides indispensable support to corporate, institutional and individual innovators seeking to validate and commercialize their products and ideas.

BD Biosciences has provided life science solutions for over 45 years, from specimen collection to cell analysis and sorting by flow cytometry.

Langara Bioinformatics is the Bioinformatics program at Langara College, offering an Associate of Science Degree, Diploma, or Bachelor of Science Degree.

Welcome all to the LSBC community!

Industry Highlights

The Canadian and BC governments have announced a historic $1.2B funding agreement over the next three years, a pivotal milestone in their 10-year collaboration plan. This comprises an annual injection of $325M in new funding from the Government of Canada and the ongoing $82M per year in previously announced funding for mental health and substance use. This funding will expedite ongoing initiatives in British Columbia to enhance healthcare access and services. Learn more.

BC is hosting a fair credentials town hall with key stakeholders to discuss upcoming legislation recognizing international credentials in healthcare and other sectors. The goal is to remove barriers for internationally trained professionals by improving the recognition process. Learn more.

Canada has announced an investment of $49M via the Strategic Innovation Fund to create the Conscience Open Science Drug Discovery Network. This nationwide collaboration targets drug development gaps in critical areas like antivirals, antimicrobial resistance, and rare/pediatric diseases. Stakeholders will share results and leverage AI to accelerate drug development, reducing duplication and expediting clinical trial candidate selection. Learn more.

DNAstack has launched Omics AI - a tool that aims to accelerate lifesaving discoveries by enabling secure omics and health data sharing across global networks. Learn more. 

Kudos

Congratulations to Dr. Pieter Cullis of the University of British Columbia, who has been selected as a 2024 inductee into the Canadian Medical Hall of Fame. This is another extremely well-deserved award recognizing Pieter’s leadership in developing drug-delivery systems to treat diseases. Congrats Pieter! Learn more. See the full list of inductees here.

Kudos to Thrive Health for placing 21^st on the Globe and Mail's 2023 Report on Business ranking of Canada’s Top Growing Companies. Learn more.

Congratulations to UBC’s School of Biomedical Engineering (SBME) Postdoctoral Fellow Samantha Grist for receiving the Optica Foundation Challenge Award, recognizing early-career professionals with exceptional ideas to leverage optics and photonics and address global challenges for her research on the menopausal transition. Learn more.

Congrats to Berkley Canada for celebrating the 15^th anniversary of its founding. Here’s to the next 15 – and beyond!

Zymeworks got a special nod from Nasdaq, which recently lit up Times Square in honour of the company's 20th business anniversary! See it here.

People on the Move

SeraGene welcomes Dr. Erika Siren as its new CEO. Siren brings over a decade of experience spanning industry, entrepreneurship, and academia. Former CEO Dr. Amy Wong Strilchuk will continue as Director of Strategy and Partnerships. Learn more.

Applications Open

CIHR invites applicants for its Improving Diagnosis for Rare Disease Patients team grants to support research that will determine the best pathway to diagnose RDs by moving genomic testing toward the front end of the care pathway. Applications are due Nov. 7. Learn more.

Canada's Natural Sciences and Engineering Research Council encourages nominations for its NSERC Prizes, recognizing exceptional science and engineering research community members. Learn more here.

Michael Smith Health Research BC has released the guidelines for its 2024 Scholar and Health-Professional-Investigator competitions, which support BC’s health researchers in advancing research and improving the health outcomes of British Columbians. The LOI deadline is Nov. 21, and complete applications are due Jan 22, 2024. Learn more.

BioTalent Canada has opened applications for its 2023-2024 I.D.E.A.L. Bioscience Employer Recognition Program, recognizing organizations in the Canadian bio-economy that are leading the way in embodying the inclusion, diversity, equity and accessibility leader (IDEAL) principles and best practices needed to promote success in the sector. Applications are due Nov. 3. Learn more.

We invite you to explore our expanded list of current life sciences application opportunities by clicking on the following link: Applications Open.

#ICYMI

Until next week,

Wendy and the LSBC team

adMare BioInnovations and MaRS Discovery District Welcome Inaugural Ontario Start-Ups to Therapeutics Accelerator Program

NorthMiRS and Quthero are two ventures developing innovative technologies derived from academic research originating from the University of Toronto and associated hospitals. NorthMiRs is an early-stage biotech venture started from a discovery made in the labs of Professors G. Walker and C. dos Santos. This preclinical stage venture is focusing on the development of novel therapeutics to treat sepsis and associated conditions... READ MORE

Eupraxia Pharmaceuticals Announces Initiation of Second Cohort in Phase 1b/2a Clinical Trial in Eosinophilic Esophagitis

Eupraxia Pharmaceuticals Safety Review Committee approved dose escalation in the second cohort based on data available from the trial’s first cohort. In addition, Eupraxia has submitted to regulators an amendment to the protocol for additional assessments of efficacy and pharmacokinetics (“PK”) at six months in all cohorts. The full dataset from the first cohort will be released when completed... READ MORE

Dr.Bill Supports Physicians in B.C. By Simplifying Administration of New Payment Model, Freeing up Time for Patient Care

As part of its commitment to resolve physician billing issues, Dr.Bill, the solutions-focused medical billing platform powered by RBCx, is now working with Doctors of B.C. to offer physicians a user-friendly platform for submitting patient panels to the Medical Services Plan (MSP). The secure portal helps to ensure equitable compensation for physicians while streamlining the complexities of medical billing... READ MORE

STEMCELL Technologies Releases “Toward Sustainable Science” Report

STEMCELL Technologies, Canada’s largest biotechnology company, is releasing its first annual sustainability report. The report, entitled Toward Sustainable Science, provides a comprehensive look at STEMCELL’s environmental, social, and governance performance over the company’s 2023 Fiscal Year (July 1, 2022 through June 30, 2023)... READ MORE

Colliers Talks: Colliers’ 125 Years: Taking Risks and Making Moves

Colliers is celebrating our 125th year of doing business in Canada. That’s 125 years of leveraging our expertise and enterprising culture to accelerate the success of our people, clients and communities. To commemorate this achievement, Colliers leaders Brian Rosen and Chris McLernon came together in Toronto for a special episode of Colliers Talks to honour our roots, highlight our achievements, and look to the future – a true Canadian success story that, despite our strong legacy, is really just getting started... READ MORE

Filament Health Announces Health Canada Authorization For Phase 2 Clinical Trial Studying Botanical Psilocybin For Opioid Use Disorder

Standard treatment for OUD is opioid agonist therapy (OAT). But less than half of those who start OAT remain for 6 months, and approximately 1 in 10 patients receiving professional help due to an overdose were receiving OAT. There is a critical need for research into new interventions to support those with OUD, and research indicates that psychedelic-assisted therapy may be a promising approach... READ MORE

Sernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA Congress

Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, announced two oral presentations at the upcoming International Pancreas and Islet Transplant Association (IPITA), International Xenotransplantation Association (IXA) Cell Transplant & Regenerative Medicine Association (CTRMA) joint congress taking October 26-29, 2023 in San Diego, CA... READ MORE

Dr. Pieter Cullis named 2024 Canadian Medical Hall of Fame Inductee

The distinction honours Canadians whose outstanding leadership and contributions to medicine and the health sciences have led to extraordinary improvements in human health. Dr. Cullis, a professor in the department of biochemistry and molecular biology at UBC, is recognized for developing the lipid nanoparticle delivery technology that enables mRNA vaccines and other next-generation gene therapies... READ MORE

The Importance of Health Literacy in Chronic Airway Disease Management

Proper disease management for people with chronic airway conditions can be the difference between staying symptom-free and needing an emergency visit to the hospital. Research led by Vancouver Coastal Health Research Institute researcher Dr. Iraj Poureslami underscores the crucial role of health literacy in supporting patient adherence to prescription medications and treatment regimen suggested by respiratory doctors... READ MORE

Xenon Pharmaceuticals Announces Publication of Results from XEN1101 Phase 2b “X-TOLE” Clinical Trial in Peer-Reviewed Journal Article in JAMA Neurology

Xenon Pharmaceuticals Inc., a neurology-focused biopharmaceutical company, announced the medical journal JAMA Neurology has published peer-reviewed efficacy and safety results from the X-TOLE Phase 2b randomized clinical trial of XEN1101, a novel potassium channel opener, in adults with focal epilepsy. Importantly, the efficacy and safety findings of this clinical trial supported the further clinical development in epilepsy of XEN1101, which is currently being evaluated in Phase 3 clinical trials in patients with focal onset seizures (FOS) and primary generalized tonic-clonic seizures... READ MORE

Cytiva Opens New Manufacturing Facility and Experience Center in India

The facility will also be home to the Cytiva Experience Center which will provide immersive training programs for upstream and downstream technologies as well as digital and automation software. Additionally, customers will have greater access to thought leadership events and to demonstrations of Cytiva’s market-leading products, such as ÄKTA, Allegro, iCELLis and Sepax... READ MORE

Lonza Further Extends Collaboration with Major Biopharmaceutical Partner for Manufacturing Antibody-Drug Conjugates

Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, announced an extension of a long-term collaboration with a major global biopharmaceutical partner. The extended agreement will increase the current dedicated bioconjugation capacity fourfold by adding two new bioconjugation suites for the commercial supply of ADCs at Lonza’s Ibex® Dedicate Biopark in Visp... READ MORE

Takeda Receives Corporate Leader Award from the Daily Bread Food Bank

Takeda Canada Inc. (“Takeda”), a leading biopharmaceutical company, is pleased to announce it has received the Corporate Leader Award by the Daily Bread Food Bank for outstanding commitment to fighting hunger in the community. The award recognizes Takeda’s significant contributions to the Daily Bread Food Bank’s mission to end hunger in Toronto... READ MORE

Thrive Health Places No. 21 on Canada’s Top Growing Companies

Thrive Health is pleased to announce it placed No. 21 on the 2023 Report on Business ranking of Canada’s Top Growing Companies. In total, 425 companies earned a spot on this year’s ranking. Thrive Health, a leader in Canadian healthcare technology, recently launched their technology framework, th.care. Powering all solutions on the Thrive Health platform, th.care is a catalyst for rapid innovation in healthcare technology, allowing healthcare systems to seamlessly integrate patient-centric technology while maximizing investment in existing platforms... READ MORE

Difinity Solutions specializes in the development, commercialization and implementation of medical devices in emergency medication delivery systems. By leveraging innovation and direct clinical knowledge, they are advancing disruptive technologies in medical care.

Their flagship device currently under development is NeedSwitch, the world’s first interchangeable and modular autoinjector for emergency and lifesaving medication delivery. Their first target drug will be naloxone to help combat the opioid crisis with plans to expand as a platform technology for other lifesaving medications like epinephrine, TXA, atropine, and many more. LEARN MORE

B.C. Improving Credential Recognition for Internationally Trained Professionals

In advance of legislation this fall, the Province is holding a fair credentials town hall with internationally trained professionals, key organizations and advocates to talk about progress made on international credential recognition in health care and the work being done to expand to all sectors of the economy... READ MORE

Canada Signs $1.2 Billion Bilateral Agreement With British Columbia to Improve Health Care Over Three Years

This historic investment includes $25 billion for tailored bilateral agreements with provinces and territories, a guaranteed 5% Canada Health Transfer (CHT) increase for the next five years — amounting to $17.2 billion — and a one time CHT $2 billion top-up to address to urgent needs of emergency rooms and paediatric hospitals delivered in June 2023. Combined, these investments provide provinces and territories the flexibility to address the unique needs of their populations and geography, and accelerate health care system improvements... READ MORE

The Canadian Medical Hall of Fame Announces the 2024 Inductees

Canadian Medical Hall of Fame Laureates are Canadian citizens whose outstanding leadership and contributions to medicine and the health sciences, in Canada or abroad, have led to extraordinary improvements in human health. Their work may be a single meritorious contribution or a lifetime of superior accomplishments. Pioneers in their field, they are role models who inspire young Canadians to pursue careers in the health sciences. “The Canadian Medical Hall of Fame is proud to welcome these six individuals whose outstanding contributions to health have made Canada, and the world, a better place,” said Dr. Forbes. “Their impact is well documented, and they have earned their place alongside our 155 Laureates.”... READ MORE

Government of Canada Invests in New Open Science Drug Discovery Network

Ryan Turnbull, Parliamentary Secretary to the Minister of Innovation, Science and Industry, on behalf of the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced an investment of $49 million through the Strategic Innovation Fund for the creation of the Conscience Open Science Drug Discovery Network. This collaborative pan-Canadian network aims to address gaps in the development of potential drugs and therapeutics, particularly in areas of traditional market failures such as antivirals for pandemic preparedness, medicines for antimicrobial resistance and medicines for rare and pediatric diseases... READ MORE

Top Educators in Canada Honoured With Prime Minister’s Awards in Recognition of Their Unwavering Dedication and Commitment to Students

The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, and the Honourable Jenna Sudds, Minister of Families, Children and Social Development, on behalf of the Right Honourable Justin Trudeau, Prime Minister of Canada, announced that 74 of Canada’s top educators have received this year’s Prime Minister Awards for Teaching Excellence and Teaching Excellence in Science, Technology, Engineering and Math (STEM) and for Excellence in Early Childhood Education at the regional and national levels... READ MORE

Quality System Specialist

To succeed in this role, the applicant must be a strong Quality partner/ collaborator to drive operational efficiencies to achieve sustainable quality compliance and meet the business objectives of the site. Build strong relationships with the Quality team, internal stakeholders (such as Development & Formulation, Supply Chain, Project Management, etc.) and external suppliers to assure on-time delivery of products/ materials/ services that are quality compliant and fit for its intended purpose...LEARN MORE

Research Associate-Protein Biochemistry

Abdera Therapeutics is seeking a highly motivated and skilled Research Associate in antibody discovery programs. This position will provide an exciting and dynamic opportunity to positively contribute to research programs developing next-generation targeted radiopharmaceutical therapies...LEARN MORE

Senior Scientist Biologics

Abdera Therapeutics is seeking a highly motivated and skilled Senior Scientist in antibody discovery programs with a proven track record of research accomplishments. This position will provide an exciting and dynamic opportunity to positively contribute to research programs developing next-generation targeted radiopharmaceutical therapies...LEARN MORE

Research Associate II, Analytics

The candidate should have expertise in high-performance liquid chromatography (HPLC), mass spectrometry, and protein biochemistry for protein characterization. Experience with various extraction techniques, Agilent™ or Waters™ HPLC and mass spectrometry equipment, AKTA™ purification systems, biological matrices like plasma and serum, and Orbitrap™ mass spectrometry instrumentation would be advantageous. General knowledge of antibody and antibody drug conjugate structure/function is also considered a valuable asset...LEARN MORE

Animal Research Associate II

This role involves applying preclinical mouse pharmacology models for cancer therapy research. Responsibilities include handling mice for various procedures, preparing drugs using sterile techniques, managing human immune cell injections, coordinating sample handling, maintaining records, and ensuring adherence to scientific standards and regulations. Effective organization, teamwork, and adherence to established protocols are essential, while fostering collaborative relationships with colleagues and management is encouraged...LEARN MORE

Senior Research Associate I, In Vitro Pharmacology

This position involves planning and executing advanced experiments, troubleshooting methods, and independently analyzing and interpreting data. The role includes designing animal studies, contributing to project planning and coordination, staying updated on relevant scientific literature, maintaining inventory databases, and potentially training junior staff. The candidate is expected to adhere to scientific standards, safety regulations, and lab protocols while actively contributing to collaborative work environments and potentially co-authoring scientific papers...LEARN MORE

Scientist, DMPK/ADME

If you are selected for this position, you will be lead oversight of contract research partners and in-house development of in vitro DMPK assays, contributing to their optimization and methodology enhancement. Independently design experiments for assessing pharmacokinetics and pharmacodynamics of small molecules and ADCs, establishing in vitro to in vivo correlations, and collaborating across disciplines to advance drug development programs. Maintain up-to-date knowledge in drug metabolism and pharmacokinetics, adhere to data generation protocols, and foster collaborative relationships with colleagues and management...LEARN MORE

Associate Scientist, In Vivo Pharmacology

The ideal candidate should have expertise in xenograft, syngeneic, or humanized mouse tumor models (PBMC/CD34) and a strong grasp of immune cell function. Proficiency in animal handling, dosing, and sample collection, especially tail vein injections, is essential. They should also demonstrate knowledge of in vivo cancer models, antibody-based therapeutics, immune cell isolation, strong organizational skills, experience with contract research organizations, and effective teamwork within scientific project teams...LEARN MORE

Controller

The Employee will carry out standard job responsibilities and any additional tasks assigned by the Company, including financial management, policy enforcement, budgeting, tax coordination, audit oversight, control maintenance, reporting enhancement, compliance support, variance analysis, insurance management, stock options, governance assistance, benefits administration, and other duties as directed by the CFO and Executives...LEARN MORE

Quality Assurance Specialist

Filament Health is looking for an enthusiastic individual with a keen eye for detail to fill the role of Quality Assurance Specialist with experience in the pharmaceutical industry. Reporting to the Quality Director, the ideal candidate will be a self-starter who needs minimal oversight and thrives in a dynamic work environment. They will provide quality support to ensure adherence to Good Documentation and Production Practices, Health Canada regulations as well as international jurisdictions such as the US, EU, UK and Australia...LEARN MORE

Project Coordinator, Research and Innovation (R&I)

As the Project Manager for Research and Innovation (R&I) Agrifood and Natural Resources (ANR), you will primarily provide project management and administrative support to the R&I Senior Manager, ANR. Additionally, you will informally report to the Director of Operations to ensure alignment with processes and effective reporting of any issues that may arise during project management...LEARN MORE

Events Specialist (Co-op Student)

Life Sciences BC is looking for an enthusiastic new co-op student to assist with

preparations and execution of both in-person and virtual events. With several scheduled events happening between January and April, this role will offer a varied mix of tasks and projects and will provide fantastic experience for the chosen candidate to see how a professional industry association operates. This position will report to the Manager, Events...LEARN MORE

Partnerships & Memberships Specialist (Co-op Student)

Life Sciences BC is looking for an enthusiastic new co-op student to help maximize potential revenue opportunities and lead generation throughout the term. This role will offer a varied mix of tasks and projects and will provide fantastic experience for the chosen candidate to see how a professional industry association operates. This position will report to the Manager, Partnerships and Memberships...LEARN MORE

Marketing & Communications Specialist (Co-op Student)

In this limited-term role, you'll work alongside our Marketing and Communications Manager, contributing your skills to the planning and execution of diverse marketing and communications initiatives. This is an exceptional chance to acquire practical expertise while leaving your mark on both the life sciences field and the world of marketing and communications...LEARN MORE

Vice President, Corporate Development

The VP, Corporate Development supports the delivery of the corporate mandate in close cooperation with other members of the management team by: building relationships with key stakeholders, including government; delivering cross-functional programs and initiatives; and, taking the lead on emerging opportunities...LEARN MORE

Canada’s Immuno-Engineering and Biomanufacturing Hub - Industry Partnership Manager

Working under broad directions of the Executive Director of CIEBH, the Industry Partnership Manager will develop and mobilize academic and hospital discoveries originating from the University and its Affiliated Hospitals, through fostering sponsored research, supporting entrepreneurship, developing and implementing knowledge mobilization plans, engaging with researchers and industry, and conducting evaluations...LEARN MORE

Animal Technician

Alpha-9 is seeking a team-oriented Animal Research Technician to join the Translational Biology group within the organization. The ideal candidate will have experience in providing technical in vivo support for research programs, preferably with radioactive substances. This person will be responsible for laboratory animal care and well-being, in addition to conducting in vivo research experiments with experimental radiopharmaceuticals...LEARN MORE

Mintz is a leading 600+ attorney law firm with deep experience in the life sciences industry. We help entrepreneurs launch and protect great ideas, work with leading industry investors and underwriters in innovative financings and offerings, and counsel emerging as well as established and public companies in all aspects of their businesses.

In March 2023, Mintz launched its first Canadian office with the country’s leading life sciences practitioners. To learn more about our team, please visit www.mintz.com. LEARN MORE

The Centre for Molecular Medicine and Therapeutics (CMMT) is a UBC Research Centre with a scientific mandate to ascertain cellular and protein function relevant to human disease as the key to improved diagnosis, treatment and prevention of health problems in children and adults.

Investigators at the CMMT are working to advance understanding of the roles of environment and genetics in child and adult health and disease, and to develop new treatments and therapies. LEARN MORE

Stay current by subscribing to this and our events newsletter!

Follow LSBC on Social Media!